Ketone bodies, the main one being β-hydroxybutyrate, have emerged as important regulators of the cardiovascular system. In healthy individuals, as well as in individuals with heart failure or post-myocardial infarction, ketones provide a supplemental energy source for both the heart and the vasculature. In the failing heart, this additional energy may contribute to improved cardiac performance, whereas increasing ketone oxidation in vascular smooth muscle and endothelial cells enhances cell proliferation and prevents blood vessel rarefication. Ketones also have important actions in signaling pathways, posttranslational modification pathways and gene transcription; many of which modify cell proliferation, inflammation, oxidative stress, endothelial function and cardiac remodeling. Attempts to therapeutically increase ketone delivery to the cardiovascular system are numerous and have shown mixed results in terms of effectiveness.Here we review the bioenergetic and signaling effects of ketones on the cardiovascular system, and we discuss how ketones can potentially be used to treat cardiovascular diseases.Cardiovascular (CV) disease is the leading cause of morbidity and mortality in the world, which creates a major burden on societies, as well as health care systems and economies. Heart failure, ischemic heart disease, arrhythmias, cardiomyopathies, stroke, atherosclerosis and hypertension, are all common forms of CV disease. Because of the prevalence and adverse consequences of CV disease, major efforts and advances have been made in treating these CV diseases. This includes treatments for diabetes, obesity and dyslipidemias, which are major comorbidities that contribute to the incidence and severity of CV disease. Alterations in heart and vascular energy metabolism are also hallmarks of CV disease 1-3 ; therefore, therapies targeting energy metabolism are also potential viable approaches to treating CV diseases.The heart has a very high energy (ATP) demand that is primarily met by the mitochondrial metabolism of various energy substrates such as fatty acids, glucose, lactate, amino acids and ketones. Mitochondrial metabolism of these energy substrates also occurs in the vasculature, although glycolysis is a more prominent source of ATP production 2 . Of the different energy substrates, recent interest has focused on ketone bodies as a source of energy for the heart and vasculature 2,4-10 . Ketone bodies are an important alternative source of fuel, particularly during times of nutrient deprivation 2,9-12 . Ketone bodies consist of β-hydroxybutyrate (βOHB), acetoacetate and acetone,